PDT Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

PDT Partners’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-23,732	Closed	-$389K	–	1098
2015 Q3	$389K	Sell	23,732 -11,319	-32%	-$232K	0.01%	978
2015 Q2	$800K	Buy	+35,051	New	+$698K	0.02%	807
2014 Q3	–	Sell	-40,704	Closed	-$492K	–	1696
2014 Q2	$492K	Sell	40,704 -173,677	-81%	-$2.05M	0.01%	1021
2014 Q1	$2.5M	Buy	214,381 +63,200	+42%	+$1.07M	0.06%	394
2013 Q4	$2.67M	Sell	151,181 -22,530	-13%	-$379K	0.32%	51
2013 Q3	$2.5M	Sell	173,711 -5,489	-3%	-$84K	0.07%	400
2013 Q2	$2.7M	Buy	+179,200	New	+$2.36M	0.07%	412

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PDT Partners's MNTA Position: Q4 2015 in Review

PDT Partners sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2015, closing a stake of 23,732 shares — an estimated $389K sold.

PDT Partners first reported a position in MNTA in Q2 2013 and held it in 7 quarters. The position peaked at $2.7M in Q2 2013. 164 funds tracked by Wall St. Rank hold MNTA as of Q4 2015.

PDT Partners reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
PDT Partners sold 23,732 Momenta Pharmaceuticals, Inc. shares in Q4 2015, an estimated $389K.
PDT Partners first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 7 quarters.
PDT Partners's Momenta Pharmaceuticals, Inc. position peaked at $2.7M in Q2 2013.
164 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2015.

Based on PDT Partners's 13F filing for Q4 2015, filed 16 Feb 2016.